Chemical Products Listed by CAS Registry Number
[ 588702-67-4 ] - [ 595597-00-5 ]
|
|
CAS No
|
Product Name
|
Molecular Formula
|
|
588702-67-4
|
4-(Trifluoromethyl)quinoline-2-carboxylic acid
|
C11H6F3NO2
|
|
588702-68-5
|
2-(Trifluoromethyl)-4-pyridinecarboxylic acid methyl ester
|
C8H6F3NO2
|
|
588706-66-5
|
Ophiopogonanone E
|
C19H20O7
|
|
588706-67-6
|
7,2'-Dihydroxy-5,8,4'-trimethoxy-6-methylhomoisoflavanone
|
C20H22O7
|
|
588708-72-9
|
3-Fluoro-4-(4-morpholinyl)benzoic acid
|
C11H12FNO3
|
|
588720-12-1
|
Ethyl 6-bromopyrrolo[1,2-c]pyrimidine-3-carboxylate
|
C10H9BrN2O2
|
|
588720-14-3
|
7-Chloropyrrolo[1,2-c]pyrimidine-3-carboxylic acid hydrochloride
|
C8H5ClN2O2.HCl
|
|
588720-29-0
|
Imidazo[1,5-a]pyridine-7-carboxylic acid
|
C8H6N2O2
|
|
588720-53-0
|
Pyrrolo[1,2-a]pyrazine-3-carboxylic acid
|
C8H6N2O2
|
|
588729-99-1
|
2-Chloro-3-amino-5-bromopyridine
|
C5H4BrClN2
|
|
588730-16-9
|
N,4-Dimethyl-1,2,5-oxadiazole-3-methanamine
|
C5H9N3O
|
|
590368-25-5
|
WX 671
|
C32H47N5O6S
|
|
590371-38-3
|
3-(Trifluoromethyl)isonicotinic acid
|
C7H4F3NO2
|
|
590371-58-7
|
3-Bromo-2-trifluoromethylpyridine
|
C6H3BrF3N
|
|
590371-71-4
|
3-Iodo-2-(trifluoromethyl)pyridine
|
C6H3F3IN
|
|
590371-73-6
|
4-Iodo-2-(trifluoromethyl)pyridine
|
C6H3F3IN
|
|
590371-81-6
|
2-Chloro-4-(trifluoromethyl)nicotinic acid
|
C7H3ClF3NO2
|
|
590371-90-7
|
4-Chloro-3-iodoquinoline
|
C9H5ClIN
|
|
590371-93-0
|
4-Chloro-3-(trifluoromethyl)quinoline
|
C10H5ClF3N
|
|
590371-97-4
|
4-Bromo-3-(trifluoromethyl)quinoline
|
C10H5BrF3N
|
|
590372-17-1
|
2-Bromo-4-(trifluoromethyl)quinoline
|
C10H5BrF3N
|
|
590390-88-8
|
2-Pyridin-4-yl-1H-indole-3-carbaldehyde
|
C14H10N2O
|
|
590393-14-9
|
N-(3-Chloro-4-methylphenyl)-N'-[1-(1-cycloocten-1-ylmethyl)-4-piperidinyl]urea
|
C22H32ClN3O
|
|
590417-56-4
|
1-Methyl-1H-indole-4-boronic acid
|
C9H10BNO2
|
|
590417-93-9
|
4-Bromo-2-methyl-2H-indazole
|
C8H7BrN2
|
|
590417-94-0
|
6-Bromo-1-methyl-1H-indazole
|
C8H7BrN2
|
|
590417-95-1
|
6-Bromo-2-methyl-2H-indazole
|
C8H7BrN2
|
|
590418-08-9
|
1-Methylindazol-5-ylboronic acid
|
C8H9BN2O2
|
|
590423-30-6
|
(4-Methoxytetralin-1-yl)amine
|
C11H15NO
|
|
590424-04-7
|
4-[[[2-(Diethylamino)ethyl]amino]carbonyl]-3,5-dimethyl-1H-pyrrole-2-carboxylic acid 1,1-dimethylethyl ester
|
C18H31N3O3
|
|
591230-99-8
|
Disodium trans-crocetinate
|
C20H24O4.Na2
|
|
591234-45-6
|
1(3H)-Isobenzofuranone-1-11C
|
C8H6O2
|
|
591769-05-0
|
3-Cyclopentylacrylonitrile
|
C8H11N
|
|
591773-92-1
|
10-[1,1'-Biphenyl]-4-yl-2-(1-methylethyl)-9-oxo-9H-thioxanthenium hexafluorophosphate
|
C28H23OS.PF6
|
|
591778-68-6
|
CP 640186
|
C30H35N3O3
|
|
591779-91-8
|
(R,R)-3,5-Dimethylmorpholine
|
C6H13NO
|
|
592533-90-9
|
(3aS,4R,6S,6aR)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol
|
C8H15NO3
|
|
592542-51-3
|
4-Methoxy-3-nitrobenzylsulfonylacetic acid
|
C10H11NO7S
|
|
592542-59-1
|
Rigosertib
|
C21H25NO8S
|
|
592542-60-4
|
Rigosertib sodium
|
C21H24NO8S.Na
|
|
593270-82-7
|
2-Bromo-1-(2-methylpyridin-3-yl)ethanone
|
C8H8BrNO
|
|
593287-40-2
|
1-[1-[2-[4,7,10-Tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-proline]-4-L-tyrosine-bombesin
|
C90H136N28O25S
|
|
593960-11-3
|
PIK 93
|
C14H16ClN3O4S2
|
|
593960-46-4
|
5-(1-Bromo-2-oxopropyl)-2-methoxybenzenesulfonamide
|
C10H12BrNO4S
|
|
594823-67-3
|
3-Bromophenylboronic acid pinacol ester
|
C12H16BBrO2
|
|
594836-83-6
|
1,4-Butanediol bis(3-mercaptobutyrate)
|
C12H22O4S2
|
|
594839-88-0
|
2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid
|
C14H7Cl2NO3
|
|
594841-23-3
|
Methyl 6-O-[(1,1-dimethylethyl)dimethylsilyl]-alpha-D-galactopyranoside triacetate
|
C19H34O9Si
|
|
595566-61-3
|
Pagibaximab
|
|
|
595597-00-5
|
tert-Butyl (tetrahydro-2H-thiopyran-4-yl)carbamate
|
C10H19NO2S
|
